Table 4 Incidence of adverse outcomes in new-onset NSTEMI patients according to the TBIL tertiles
Variables | 1st tertile < 10.23 umol/L (n = 109) | 2nd tertile 10.23–14.30 μmol/L (n = 109) | 3rd tertile ≥ 14.30 μmol/L (n = 109) | χ2 | p value |
|---|---|---|---|---|---|
MACCEs, n (%) | 7 (6.4) | 23 (21.1) | 27 (24.8) | 14.278 | 0.001 |
Sudden cardiac death, n (%) | 7 (6.4) | 5 (4.6) | 8 (7.3) | 0.746 | 0.689 |
Recurrent MI, n (%) | 3 (2.8) | 6 (5.5) | 7 (6.4) | 1.709 | 0.426 |
Revascularization, n (%) | 5 (4.6) | 14 (12.8) | 18 (16.5) | 9.041 | 0.011 |
Stroke, n (%) | 0 (0.0) | 4 (3.7) | 4 (3.7) | 6.587 | 0.037 |
Stent thrombosis, n (%) | 4 (3.7) | 5 (4.6) | 4 (3.7) | 0.157 | 0.925 |
All-cause mortality, n (%) | 4 (3.7) | 8 (7.3) | 11 (10.1) | 3.461 | 0.177 |